At a glance
- Originator Merck Frosst
- Class Antiasthmatics; Antithrombotics; Bronchodilators
- Mechanism of Action Thromboxane receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Arrhythmias; Asthma; Ischaemic heart disorders